Geert Cauwenbergh, President & CEO at RXi Pharmaceuticals Corp (RXII), bought 2,500 shares at $1.59 ($4K) on 2014-12-30, disclosed to the SEC on 2014-12-31.
Open-market purchase of $4k RXII by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.59 | 500 | $795 | 20.0% |
| 2 | $1.59 | 2,000 | $3K | 80.0% |
| Total | $1.59 avg | 2,500 | $4K | 100% |
| Filing → |
| RXII | BUY | 2017-06-22 | $6K | — | Filing → |
| RXII | BUY | 2017-04-26 | $7K | — | Filing → |
| RXII | BUY | 2017-03-20 | $8K | — | Filing → |